Epithelium: the interplay between innate and Th2 immunity

被引:87
作者
Bulek, Katarzyna [1 ]
Swaidani, Shadi [1 ,2 ,3 ]
Aronica, Mark [2 ]
Li, Xiaoxia [1 ]
机构
[1] Cleveland Clin, Dept Immunol, Cleveland, OH 44106 USA
[2] Cleveland Clin Fdn, Dept Pathobiol, Cleveland, OH 44195 USA
[3] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA
关键词
asthma; epithelium; IL-25; IL-33; Th2; TSLP; THYMIC STROMAL LYMPHOPOIETIN; REGULATORY T-CELLS; TOLL-LIKE RECEPTORS; ALLERGIC AIRWAY INFLAMMATION; IGM(+) B-CELLS; DENDRITIC CELLS; ADAPTIVE IMMUNITY; FAMILY-MEMBER; CUTTING EDGE; IN-VITRO;
D O I
10.1038/icb.2009.113
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mucosal epithelium functions not only as a physical barrier, but also as a regulator of innate and adaptive immune responses against foreign substances and microorganisms. In particular, epithelial cells have been directly implicated in Th2 responses, serving as a critical interface between innate immune responses and Th2 immunity. Emerging studies have revealed the cellular and molecular mechanisms by which the epithelium modulates Th2 responses through the production of a group of epithelial-derived Th2-driving cytokines, including interleukin (IL)-25, IL-33, and thymic stromal lymphopoietin. These epithelial-derived Th2-driving cytokines execute a regulatory function of the epithelium on mucosal immunity by promoting Th2 responses and maintaining the balance of host immune homeostasis and defense against various pathogens. Dysregulation of these Th2-driving cytokines can lead to detrimental Th2-dependent inflammatory responses, often manifested in various forms of allergic and inflammatory diseases. Immunology and Cell Biology (2010) 88, 257-268; doi: 10.1038/icb.2009.113; published online 12 January 2010
引用
收藏
页码:257 / 268
页数:12
相关论文
共 171 条
[1]   TLR signaling at the intestinal epithelial interface [J].
Abreu, MT ;
Thomas, LS ;
Arnold, ET ;
Lukasek, K ;
Michelsen, KS ;
Arditi, M .
JOURNAL OF ENDOTOXIN RESEARCH, 2003, 9 (05) :322-330
[2]   TLR signaling in the gut in health and disease [J].
Abreu, MT ;
Fukata, M ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4453-4460
[3]   Toll-like receptors: critical proteins linking innate and acquired immunity [J].
Akira, S ;
Takeda, K ;
Kaisho, T .
NATURE IMMUNOLOGY, 2001, 2 (08) :675-680
[4]   A role for TSLP in the development of inflammation in an asthma model [J].
Al-Shami, A ;
Spolski, R ;
Kelly, J ;
Keane-Myers, A ;
Leonard, WJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06) :829-839
[5]   Thymic stfomal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells [J].
Allakhverdi, Zoulfia ;
Comeau, Michael R. ;
Jessup, Heidi K. ;
Yoon, Bo-Rin Park ;
Brewer, Avery ;
Chartier, Suzanne ;
Paquette, Nicole ;
Ziegler, Steven F. ;
Sarfati, Marika ;
Delespesse, Guy .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (02) :253-258
[6]   Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells [J].
Allakhverdi, Zouna ;
Smith, Dirk E. ;
Comeau, Michael R. ;
Delespesse, Guy .
JOURNAL OF IMMUNOLOGY, 2007, 179 (04) :2051-2054
[7]   Interleukin 25 promotes the initiation of proallergic type 2 responses [J].
Angkasekwinai, Pornpimon ;
Park, Heon ;
Wang, Yui-Hsi ;
Wang, Yi-Hong ;
Chang, Seon Hee ;
Corry, David B. ;
Liu, Yong-Jun ;
Zhu, Zhou ;
Dong, Chen .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (07) :1509-1517
[8]   Essential role for CD103 in the T cell-mediated regulation of experimental colitis [J].
Annacker, O ;
Coombes, JL ;
Malmstrom, V ;
Uhlig, HH ;
Bourne, T ;
Johansson-Lindbom, B ;
Agace, WW ;
Parker, CM ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1051-1061
[9]   Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut [J].
Artis, David .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (06) :411-420
[10]   House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: The cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1 [J].
Asokananthan, N ;
Graham, PT ;
Stewart, DJ ;
Bakker, AJ ;
Eidne, KA ;
Thompson, PJ ;
Stewart, GA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4572-4578